MBX Biosciences Company

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Technology:
Others
Industry:
PharmTech
Headquarters:
Carmel, Indiana, United States
Founded Date:
2019
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
6
Total Funding:
$59.9M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series A
Register and Claim Ownership